Mint Tower Capital Management
NAMSW icon

Mint Tower Capital Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Mint Tower Capital Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,533
Closed -$12K – 292
2023
Q1 		$12K Hold
6,533
– – ﹤0.01% 219
2022
Q4 		$6K Buy
+6,533
New +$5.38K ﹤0.01% 323

Other funds holding NAMSW

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Westchester Capital Management (New York)
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Mint Tower Capital Management's NAMSW Position: Q2 2023 in Review

Mint Tower Capital Management sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q2 2023, closing a stake of 6,533 shares — an estimated $12K sold.

Mint Tower Capital Management first reported a position in NAMSW in Q4 2022 and held it in 2 quarters. The position peaked at $12K in Q1 2023. 18 funds tracked by Wall St. Rank hold NAMSW as of Q2 2023.

  • Mint Tower Capital Management reported no remaining NewAmsterdam Pharma Warrant position as of Q2 2023 after selling out during the quarter.
  • Mint Tower Capital Management sold 6,533 NewAmsterdam Pharma Warrant shares in Q2 2023, an estimated $12K.
  • Mint Tower Capital Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 2 quarters.
  • Mint Tower Capital Management's NewAmsterdam Pharma Warrant position peaked at $12K in Q1 2023.
  • 18 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q2 2023.

Based on Mint Tower Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.